TORVANTA
Other · S&P 500 · data as of 2026-10-05

NEOG stock analysis: NEOG

NEOG (NEOG) is an S&P 500 company in Other. It grades strongest on momentum and weakest on profitability and value.

The model's view of NEOG · subscribers

Where NEOG ranks among the 1,500 U.S. stocks the model scores each trading day, its expected return, the evidence for and against it, and whether the model portfolio holds it. The grades below describe the company's data; they are not the model's view.

See plans
What's happening with NEOG · updated 2026-10-05 · from prices and SEC filings

NEOG price performance

NEOG against the S&P 500, one year
+0%+50%+100%+150%NEOG +133%S&P 500 +18%2025-09-292026-10-05
Year to date+86.1%S&P 500 +14.5% · ahead by 71.6 pts
1 year+114.7%S&P 500 +17.0% · ahead by 97.7 pts
3 years-24.4%S&P 500 +89.3% · behind by 113.7 pts
5 years-69.5%S&P 500 +91.3% · behind by 160.8 pts

Total returns with dividends reinvested.

NEOG factor grades

Each grade compares NEOG with the rest of its sector (A+ best, F worst); the numbers behind it are shown with the typical figure for its peers.

D-ValueFCF yield 1.1% (industry 6.0%)
–GrowthRevenue growth -3% (industry +8%)
D+ProfitabilityOperating margin -2.5% (industry 9.6%)ROIC -0.6% (industry 10.1%)
AMomentum12-month change +115%From 52-wk high -7%

NEOG in plain numbers

NEOG key statistics

SectorOther
Industryn/a
IndexS&P 500
Market value$2.8B
Revenue growth (y/y)-3%
Free-cash-flow yield1.1%
Dividend yieldn/a
Next earnings (expected)2026-10-08
Valuation measures
Market value$2.8B
Enterprise value$3.4B
Price / sales3.3x
Price / book1.4x
EV / revenue4.0x
EV / EBITDA36.4x
Financial highlights
Revenue, last 12 months$870.4M
Net income, last 12 months-$7.9M
EPS, last 12 months (GAAP)$-0.04
Gross margin46.9%
Operating margin-2.5%
Net margin-0.9%
Return on equity-0.4%
Return on invested capital-0.6%
Cash$185.5M
Total debt$793.7M
Debt / equity0.38x
Free cash flow, last 12 months$31.9M
Current ratio3.82x

Company figures from its latest SEC filings; market value and returns from end-of-day prices.

NEOG earnings trends

Revenue vs earnings
-$612.2M-$401.3M-$190.5M$20.4M$231.3MAug 2024 Revenue: $217.0MNov 2024 Revenue: $231.3MFeb 2025 Revenue: $221.0MMay 2025 Revenue: $225.5MAug 2025 Revenue: $209.2MNov 2025 Revenue: $224.7MFeb 2026 Revenue: $211.2MMay 2026 Revenue: $225.3MAug 2024 Net income: -$12.6MNov 2024 Net income: -$456.3MFeb 2025 Net income: -$11.0MMay 2025 Net income: -$612.2MAug 2025 Net income: $36.3MNov 2025 Net income: -$15.9MFeb 2026 Net income: -$17.0MMay 2026 Net income: -$11.3MAug 2024Nov 2024Feb 2025May 2025Aug 2025Nov 2025Feb 2026May 2026Net margin: -5.8%Net margin: -197.3%Net margin: -5.0%Net margin: -271.5%Net margin: 17.4%Net margin: -7.1%Net margin: -8.0%Net margin: -5.0%-272%-127%17%■ Revenue ■ Net income ━ Net margin
Earnings per share$-2.8$-2.1$-1.3$-0.6$0.2Aug 2024 EPS (GAAP, diluted): $-0.1Nov 2024 EPS (GAAP, diluted): $-2.1Feb 2025 EPS (GAAP, diluted): $-0.1May 2025 EPS (GAAP, diluted): $-2.8Aug 2025 EPS (GAAP, diluted): $0.2Nov 2025 EPS (GAAP, diluted): $-0.1Feb 2026 EPS (GAAP, diluted): $-0.1May 2026 EPS (GAAP, diluted): $-0.1Aug 2024Nov 2024Feb 2025May 2025Aug 2025Nov 2025Feb 2026May 2026■ EPS (GAAP, diluted)

From the company's 10-Q and 10-K filings with the SEC.

NEOG financials (from SEC filings)

Fiscal yearFY2022FY2023FY2024FY2025FY2026
Revenue$527.2M$822.4M$924.2M$894.7M$870.4M
Net income$48.3M-$22.9M-$9.4M-$1.1B-$7.9M
EPS (GAAP)$0.23$-0.08$-0.04$-5.03$-0.04
Free cash flow$43.6M-$24.7M-$76.2M-$46.4M$31.9M

NEOG earnings history

ReportedEPS (GAAP)EPS y/yRevenue y/yStock vs S&P 500, 2 days
2026-07-30$-0.06n/a-0%+25.7%
2026-04-09$-0.08n/a-4%-9.4%
2026-01-08$-0.07n/a-3%+29.7%
2025-10-09$0.17n/a-4%+6.8%
2025-07-29$-2.82n/a-5%-13.0%
2025-04-09$-0.05n/a-3%-25.7%

About NEOG

HeadquartersLansing, MI
Industry (SEC code)In Vitro & In Vivo Diagnostic Substances
Fiscal year endsMay 31
Incorporated inMI
Listed onNasdaq

From the company's SEC registration record.

Companies similar to NEOG

CompanyMarket valueP/ERevenue growthOperating margin12-month change
NEOG NEOG$2.8Bn/a-3%-2.5%+115%
CWT CWT$2.8B20.6x+4%18.5%+4%compare
ROG ROG$2.8Bn/a+2%-4.1%+92%compare
TALO TALO$2.8Bn/a+2%-12.7%+73%compare
ABM ABM$2.8B17.5x+6%3.5%+7%
CXT CXT$2.8B20.4x+17%14.0%-25%
DGII DGII$2.8B59.2x+20%13.9%+105%

All Other stock ratings

Frequently asked questions

Is NEOG stock a buy?

Torvanta does not tell individuals what to buy. Its grades for NEOG are shown above. Subscribers see the model's rank, expected return and whether the model portfolio holds it. This is research, not a recommendation.

When does NEOG report earnings next?

Based on its filing history, Torvanta expects NEOG to report around 2026-10-08.

How has NEOG performed against the S&P 500?

Over the past year NEOG returned +114.7%, against +17.0% for the S&P 500, dividends reinvested.

See the model's view

Subscribers get the model's rank and expected return for every covered company, the reasoning behind each, and the Torvanta model portfolio's trades each trading day, sized and explained, at three risk levels.

See plans Or get the free weekly newsletter

Torvanta is research only - not investment advice and not a recommendation to buy or sell any security. Grades describe a company's reported data against its sector; they are not the model's view, change as data changes and can be wrong. Financial figures come from the company's SEC filings; returns include reinvested dividends. Past performance does not predict future results.

All stock ratings · Stock lists · AI stock research · Model portfolio · Research · Disclaimer